1h Free Analyst Time
The global urea cycle disorder treatment market is forecasted to grow by USD 240.13 million during 2025-2030, accelerating at a CAGR of 3.3% during the forecast period. The report on the global urea cycle disorder treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by mainstreaming of curative gene therapies and industrialization of aav delivery vectors, expansion of precision diagnostics and strategic rise of comprehensive newborn screening and rapid genetic sequencing, evolution of patient-centric oral formulations and strategic demand for taste-masked and sustained-release ammonia scavengers.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global urea cycle disorder treatment market is segmented as below:
By Therapy
- Glycerol phenylbutyrate
- Sodium phenylbutyrate
- Amino acid supplements
- Sodium benzoate
- Others
By Route Of Administration
- Oral
- Injectables
By End-User
- Hospitals
- Specialized clinics
- Home care settings
- Research institutions
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (RoW)
- Rest of World (RoW)
The report on the global urea cycle disorder treatment market covers the following areas:
- Global urea cycle disorder treatment market sizing
- Global urea cycle disorder treatment market forecast
- Global urea cycle disorder treatment market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Therapy
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Global - Market size and forecast 2025-2030 ($ thousand)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Urea Cycle Disorder Treatment Market 2020 - 2024
- Historic Market Size - Data Table on Global Urea Cycle Disorder Treatment Market 2020 - 2024 ($ thousand)
- Historic Market Size - Therapy Segment 2020 - 2024 ($ thousand)
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ thousand)
- Historic Market Size - End-user Segment 2020 - 2024 ($ thousand)
- Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
- Historic Market Size - Country Segment 2020 - 2024 ($ thousand)
6 Qualitative Analysis
6.1 Impact of AI in global urea cycle disorder treatment market
6.2 Impact of geopolitical conflict for global urea cycle disorder treatment market
6.2 Impact of geopolitical conflict for global urea cycle disorder treatment market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Therapy
8.1 Market segments
- Chart on Therapy - Market share 2025-2030 (%)
- Data Table on Therapy - Market share 2025-2030 (%)
- Chart on Comparison by Therapy
- Data Table on Comparison by Therapy
- Chart on Glycerol phenylbutyrate - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Glycerol phenylbutyrate - Market size and forecast 2025-2030 ($ thousand)
- Chart on Glycerol phenylbutyrate - Year-over-year growth 2025-2030 (%)
- Data Table on Glycerol phenylbutyrate - Year-over-year growth 2025-2030 (%)
- Chart on Sodium phenylbutyrate - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Sodium phenylbutyrate - Market size and forecast 2025-2030 ($ thousand)
- Chart on Sodium phenylbutyrate - Year-over-year growth 2025-2030 (%)
- Data Table on Sodium phenylbutyrate - Year-over-year growth 2025-2030 (%)
- Chart on Amino acid supplements - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Amino acid supplements - Market size and forecast 2025-2030 ($ thousand)
- Chart on Amino acid supplements - Year-over-year growth 2025-2030 (%)
- Data Table on Amino acid supplements - Year-over-year growth 2025-2030 (%)
- Chart on Sodium benzoate - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Sodium benzoate - Market size and forecast 2025-2030 ($ thousand)
- Chart on Sodium benzoate - Year-over-year growth 2025-2030 (%)
- Data Table on Sodium benzoate - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Others - Market size and forecast 2025-2030 ($ thousand)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Therapy ($ thousand)
- Data Table on Market opportunity by Therapy ($ thousand)
9 Market Segmentation by Route of Administration
9.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Oral - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Oral - Market size and forecast 2025-2030 ($ thousand)
- Chart on Oral - Year-over-year growth 2025-2030 (%)
- Data Table on Oral - Year-over-year growth 2025-2030 (%)
- Chart on Injectables - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Injectables - Market size and forecast 2025-2030 ($ thousand)
- Chart on Injectables - Year-over-year growth 2025-2030 (%)
- Data Table on Injectables - Year-over-year growth 2025-2030 (%)
- Market opportunity by Route of Administration ($ thousand)
- Data Table on Market opportunity by Route of Administration ($ thousand)
10 Market Segmentation by End-user
10.1 Market segments
- Chart on End-user - Market share 2025-2030 (%)
- Data Table on End-user - Market share 2025-2030 (%)
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- Chart on Hospitals - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Hospitals - Market size and forecast 2025-2030 ($ thousand)
- Chart on Hospitals - Year-over-year growth 2025-2030 (%)
- Data Table on Hospitals - Year-over-year growth 2025-2030 (%)
- Chart on Specialized clinics - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Specialized clinics - Market size and forecast 2025-2030 ($ thousand)
- Chart on Specialized clinics - Year-over-year growth 2025-2030 (%)
- Data Table on Specialized clinics - Year-over-year growth 2025-2030 (%)
- Chart on Home care settings - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Home care settings - Market size and forecast 2025-2030 ($ thousand)
- Chart on Home care settings - Year-over-year growth 2025-2030 (%)
- Data Table on Home care settings - Year-over-year growth 2025-2030 (%)
- Chart on Research institutions - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Research institutions - Market size and forecast 2025-2030 ($ thousand)
- Chart on Research institutions - Year-over-year growth 2025-2030 (%)
- Data Table on Research institutions - Year-over-year growth 2025-2030 (%)
- Market opportunity by End-user ($ thousand)
- Data Table on Market opportunity by End-user ($ thousand)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ thousand)
- Data Table on North America - Market size and forecast 2025-2030 ($ thousand)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ thousand)
- Data Table on US - Market size and forecast 2025-2030 ($ thousand)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Canada - Market size and forecast 2025-2030 ($ thousand)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ thousand)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Europe - Market size and forecast 2025-2030 ($ thousand)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Germany - Market size and forecast 2025-2030 ($ thousand)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ thousand)
- Data Table on UK - Market size and forecast 2025-2030 ($ thousand)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ thousand)
- Data Table on France - Market size and forecast 2025-2030 ($ thousand)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Italy - Market size and forecast 2025-2030 ($ thousand)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Spain - Market size and forecast 2025-2030 ($ thousand)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Asia - Market size and forecast 2025-2030 ($ thousand)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ thousand)
- Data Table on China - Market size and forecast 2025-2030 ($ thousand)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Japan - Market size and forecast 2025-2030 ($ thousand)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ thousand)
- Data Table on India - Market size and forecast 2025-2030 ($ thousand)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ thousand)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ thousand)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ thousand)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ thousand)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ thousand)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ thousand)
- Data Table on UAE - Market size and forecast 2025-2030 ($ thousand)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ thousand)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ thousand)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on Colombia - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Colombia - Market size and forecast 2025-2030 ($ thousand)
- Chart on Colombia - Year-over-year growth 2025-2030 (%)
- Data Table on Colombia - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ thousand)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ thousand)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Israel - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Israel - Market size and forecast 2025-2030 ($ thousand)
- Chart on Israel - Year-over-year growth 2025-2030 (%)
- Data Table on Israel - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ thousand)
- Data Tables on Market opportunity by geography ($ thousand)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Mainstreaming of curative gene therapies and industrialization of AAV delivery vectors
- Expansion of precision diagnostics and strategic rise of comprehensive newborn screening and rapid genetic sequencing
- Evolution of patient-centric oral formulations and strategic demand for taste-masked and sustained-release ammonia scavengers
- Financial burden of orphan drug pricing and resistance of global reimbursement frameworks
- Logistical complexity of lifelong adherence and clinical risk of chronic treatment fatigue
- Technical debt of diagnostic infrastructure and geographic disparity in newborn screening programs
- Impact of drivers and challenges in 2025 and 2030
- Institutionalization of mRNA-based therapeutic interventions and enzyme replacement advancements
- Proliferation of pharmacological chaperones for stabilization of misfolded metabolic proteins
- Strategic advancement of rare disease approval pathways and formalization of regulatory surrogate endpoints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key offerings
- SWOT
- ANI Pharmaceuticals Inc. - Overview
- ANI Pharmaceuticals Inc. - Product / Service
- ANI Pharmaceuticals Inc. - Key offerings
- SWOT
- Bausch Health Companies Inc. - Overview
- Bausch Health Companies Inc. - Business segments
- Bausch Health Companies Inc. - Key offerings
- Bausch Health Companies Inc. - Segment focus
- SWOT
- Danone SA - Overview
- Danone SA - Business segments
- Danone SA - Key offerings
- Danone SA - Segment focus
- SWOT
- Dr. Reddys Laboratories Ltd. - Overview
- Dr. Reddys Laboratories Ltd. - Business segments
- Dr. Reddys Laboratories Ltd. - Key news
- Dr. Reddys Laboratories Ltd. - Key offerings
- Dr. Reddys Laboratories Ltd. - Segment focus
- SWOT
- Lucane Pharma SA - Overview
- Lucane Pharma SA - Product / Service
- Lucane Pharma SA - Key offerings
- SWOT
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
- Navinta LLC - Overview
- Navinta LLC - Product / Service
- Navinta LLC - Key offerings
- SWOT
- Nestle SA - Overview
- Nestle SA - Business segments
- Nestle SA - Key news
- Nestle SA - Key offerings
- Nestle SA - Segment focus
- SWOT
- Reckitt Benckiser Group Plc - Overview
- Reckitt Benckiser Group Plc - Business segments
- Reckitt Benckiser Group Plc - Key offerings
- Reckitt Benckiser Group Plc - Segment focus
- SWOT
- Recordati S.p.A - Overview
- Recordati S.p.A - Business segments
- Recordati S.p.A - Key offerings
- Recordati S.p.A - Segment focus
- SWOT
- Sigmapharm Laboratories LLC - Overview
- Sigmapharm Laboratories LLC - Product / Service
- Sigmapharm Laboratories LLC - Key offerings
- SWOT
- Swedish Orphan Biovitrum AB - Overview
- Swedish Orphan Biovitrum AB - Product / Service
- Swedish Orphan Biovitrum AB - Key offerings
- SWOT
- Teva Pharmaceutical Ltd. - Overview
- Teva Pharmaceutical Ltd. - Business segments
- Teva Pharmaceutical Ltd. - Key news
- Teva Pharmaceutical Ltd. - Key offerings
- Teva Pharmaceutical Ltd. - Segment focus
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibit 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 7: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ thousand)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ thousand)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Urea Cycle Disorder Treatment Market 2020 - 2024 ($ thousand)
Exhibit 26: Historic Market Size - Therapy Segment 2020 - 2024 ($ thousand)
Exhibit 27: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ thousand)
Exhibit 28: Historic Market Size - End-user Segment 2020 - 2024 ($ thousand)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ thousand)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Therapy - Market share 2025-2030 (%)
Exhibit 39: Data Table on Therapy - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Therapy
Exhibit 41: Data Table on Comparison by Therapy
Exhibit 42: Chart on Glycerol phenylbutyrate - Market size and forecast 2025-2030 ($ thousand)
Exhibit 43: Data Table on Glycerol phenylbutyrate - Market size and forecast 2025-2030 ($ thousand)
Exhibit 44: Chart on Glycerol phenylbutyrate - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Glycerol phenylbutyrate - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Sodium phenylbutyrate - Market size and forecast 2025-2030 ($ thousand)
Exhibit 47: Data Table on Sodium phenylbutyrate - Market size and forecast 2025-2030 ($ thousand)
Exhibit 48: Chart on Sodium phenylbutyrate - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Sodium phenylbutyrate - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Amino acid supplements - Market size and forecast 2025-2030 ($ thousand)
Exhibit 51: Data Table on Amino acid supplements - Market size and forecast 2025-2030 ($ thousand)
Exhibit 52: Chart on Amino acid supplements - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Amino acid supplements - Year-over-year growth 2025-2030 (%)
Exhibit 54: Chart on Sodium benzoate - Market size and forecast 2025-2030 ($ thousand)
Exhibit 55: Data Table on Sodium benzoate - Market size and forecast 2025-2030 ($ thousand)
Exhibit 56: Chart on Sodium benzoate - Year-over-year growth 2025-2030 (%)
Exhibit 57: Data Table on Sodium benzoate - Year-over-year growth 2025-2030 (%)
Exhibit 58: Chart on Others - Market size and forecast 2025-2030 ($ thousand)
Exhibit 59: Data Table on Others - Market size and forecast 2025-2030 ($ thousand)
Exhibit 60: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 61: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 62: Market opportunity by Therapy ($ thousand)
Exhibit 63: Data Table on Market opportunity by Therapy ($ thousand)
Exhibit 64: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 65: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 66: Chart on Comparison by Route of Administration
Exhibit 67: Data Table on Comparison by Route of Administration
Exhibit 68: Chart on Oral - Market size and forecast 2025-2030 ($ thousand)
Exhibit 69: Data Table on Oral - Market size and forecast 2025-2030 ($ thousand)
Exhibit 70: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 72: Chart on Injectables - Market size and forecast 2025-2030 ($ thousand)
Exhibit 73: Data Table on Injectables - Market size and forecast 2025-2030 ($ thousand)
Exhibit 74: Chart on Injectables - Year-over-year growth 2025-2030 (%)
Exhibit 75: Data Table on Injectables - Year-over-year growth 2025-2030 (%)
Exhibit 76: Market opportunity by Route of Administration ($ thousand)
Exhibit 77: Data Table on Market opportunity by Route of Administration ($ thousand)
Exhibit 78: Chart on End-user - Market share 2025-2030 (%)
Exhibit 79: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 80: Chart on Comparison by End-user
Exhibit 81: Data Table on Comparison by End-user
Exhibit 82: Chart on Hospitals - Market size and forecast 2025-2030 ($ thousand)
Exhibit 83: Data Table on Hospitals - Market size and forecast 2025-2030 ($ thousand)
Exhibit 84: Chart on Hospitals - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Hospitals - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Specialized clinics - Market size and forecast 2025-2030 ($ thousand)
Exhibit 87: Data Table on Specialized clinics - Market size and forecast 2025-2030 ($ thousand)
Exhibit 88: Chart on Specialized clinics - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Specialized clinics - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Home care settings - Market size and forecast 2025-2030 ($ thousand)
Exhibit 91: Data Table on Home care settings - Market size and forecast 2025-2030 ($ thousand)
Exhibit 92: Chart on Home care settings - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Home care settings - Year-over-year growth 2025-2030 (%)
Exhibit 94: Chart on Research institutions - Market size and forecast 2025-2030 ($ thousand)
Exhibit 95: Data Table on Research institutions - Market size and forecast 2025-2030 ($ thousand)
Exhibit 96: Chart on Research institutions - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Research institutions - Year-over-year growth 2025-2030 (%)
Exhibit 98: Market opportunity by End-user ($ thousand)
Exhibit 99: Data Table on Market opportunity by End-user ($ thousand)
Exhibit 100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 101: Chart on Market share by geography 2025-2030 (%)
Exhibit 102: Data Table on Market share by geography 2025-2030 (%)
Exhibit 103: Chart on Geographic comparison
Exhibit 104: Data Table on Geographic comparison
Exhibit 105: Chart on North America - Market size and forecast 2025-2030 ($ thousand)
Exhibit 106: Data Table on North America - Market size and forecast 2025-2030 ($ thousand)
Exhibit 107: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 108: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 109: Chart on Regional Comparison - North America
Exhibit 110: Data Table on Regional Comparison - North America
Exhibit 111: Chart on US - Market size and forecast 2025-2030 ($ thousand)
Exhibit 112: Data Table on US - Market size and forecast 2025-2030 ($ thousand)
Exhibit 113: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Canada - Market size and forecast 2025-2030 ($ thousand)
Exhibit 116: Data Table on Canada - Market size and forecast 2025-2030 ($ thousand)
Exhibit 117: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Mexico - Market size and forecast 2025-2030 ($ thousand)
Exhibit 120: Data Table on Mexico - Market size and forecast 2025-2030 ($ thousand)
Exhibit 121: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Europe - Market size and forecast 2025-2030 ($ thousand)
Exhibit 124: Data Table on Europe - Market size and forecast 2025-2030 ($ thousand)
Exhibit 125: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Regional Comparison - Europe
Exhibit 128: Data Table on Regional Comparison - Europe
Exhibit 129: Chart on Germany - Market size and forecast 2025-2030 ($ thousand)
Exhibit 130: Data Table on Germany - Market size and forecast 2025-2030 ($ thousand)
Exhibit 131: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on UK - Market size and forecast 2025-2030 ($ thousand)
Exhibit 134: Data Table on UK - Market size and forecast 2025-2030 ($ thousand)
Exhibit 135: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on France - Market size and forecast 2025-2030 ($ thousand)
Exhibit 138: Data Table on France - Market size and forecast 2025-2030 ($ thousand)
Exhibit 139: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Italy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 142: Data Table on Italy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 143: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Spain - Market size and forecast 2025-2030 ($ thousand)
Exhibit 146: Data Table on Spain - Market size and forecast 2025-2030 ($ thousand)
Exhibit 147: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
Exhibit 150: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
Exhibit 151: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Asia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 154: Data Table on Asia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 155: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on Regional Comparison - Asia
Exhibit 158: Data Table on Regional Comparison - Asia
Exhibit 159: Chart on China - Market size and forecast 2025-2030 ($ thousand)
Exhibit 160: Data Table on China - Market size and forecast 2025-2030 ($ thousand)
Exhibit 161: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Japan - Market size and forecast 2025-2030 ($ thousand)
Exhibit 164: Data Table on Japan - Market size and forecast 2025-2030 ($ thousand)
Exhibit 165: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on India - Market size and forecast 2025-2030 ($ thousand)
Exhibit 168: Data Table on India - Market size and forecast 2025-2030 ($ thousand)
Exhibit 169: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on South Korea - Market size and forecast 2025-2030 ($ thousand)
Exhibit 172: Data Table on South Korea - Market size and forecast 2025-2030 ($ thousand)
Exhibit 173: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Indonesia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 176: Data Table on Indonesia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 177: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Thailand - Market size and forecast 2025-2030 ($ thousand)
Exhibit 180: Data Table on Thailand - Market size and forecast 2025-2030 ($ thousand)
Exhibit 181: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 184: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 185: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 188: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 189: Chart on Brazil - Market size and forecast 2025-2030 ($ thousand)
Exhibit 190: Data Table on Brazil - Market size and forecast 2025-2030 ($ thousand)
Exhibit 191: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 194: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 195: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on UAE - Market size and forecast 2025-2030 ($ thousand)
Exhibit 198: Data Table on UAE - Market size and forecast 2025-2030 ($ thousand)
Exhibit 199: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Turkey - Market size and forecast 2025-2030 ($ thousand)
Exhibit 202: Data Table on Turkey - Market size and forecast 2025-2030 ($ thousand)
Exhibit 203: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Argentina - Market size and forecast 2025-2030 ($ thousand)
Exhibit 206: Data Table on Argentina - Market size and forecast 2025-2030 ($ thousand)
Exhibit 207: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Colombia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 210: Data Table on Colombia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 211: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on South Africa - Market size and forecast 2025-2030 ($ thousand)
Exhibit 214: Data Table on South Africa - Market size and forecast 2025-2030 ($ thousand)
Exhibit 215: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Israel - Market size and forecast 2025-2030 ($ thousand)
Exhibit 218: Data Table on Israel - Market size and forecast 2025-2030 ($ thousand)
Exhibit 219: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 221: Market opportunity by geography ($ thousand)
Exhibit 222: Data Tables on Market opportunity by geography ($ thousand)
Exhibit 223: Impact of drivers and challenges in 2025 and 2030
Exhibit 224: Overview on criticality of inputs and factors of differentiation
Exhibit 225: Overview on factors of disruption
Exhibit 226: Impact of key risks on business
Exhibit 227: Companies covered
Exhibit 228: Company ranking index
Exhibit 229: Matrix on companies position and classification
Exhibit 230: Abbott Laboratories - Overview
Exhibit 231: Abbott Laboratories - Business segments
Exhibit 232: Abbott Laboratories - Key news
Exhibit 233: Abbott Laboratories - Key offerings
Exhibit 234: Abbott Laboratories - Segment focus
Exhibit 235: SWOT
Exhibit 236: Amgen Inc. - Overview
Exhibit 237: Amgen Inc. - Product / Service
Exhibit 238: Amgen Inc. - Key offerings
Exhibit 239: SWOT
Exhibit 240: ANI Pharmaceuticals Inc. - Overview
Exhibit 241: ANI Pharmaceuticals Inc. - Product / Service
Exhibit 242: ANI Pharmaceuticals Inc. - Key offerings
Exhibit 243: SWOT
Exhibit 244: Bausch Health Companies Inc. - Overview
Exhibit 245: Bausch Health Companies Inc. - Business segments
Exhibit 246: Bausch Health Companies Inc. - Key offerings
Exhibit 247: Bausch Health Companies Inc. - Segment focus
Exhibit 248: SWOT
Exhibit 249: Danone SA - Overview
Exhibit 250: Danone SA - Business segments
Exhibit 251: Danone SA - Key offerings
Exhibit 252: Danone SA - Segment focus
Exhibit 253: SWOT
Exhibit 254: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 255: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 256: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 257: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 258: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 259: SWOT
Exhibit 260: Lucane Pharma SA - Overview
Exhibit 261: Lucane Pharma SA - Product / Service
Exhibit 262: Lucane Pharma SA - Key offerings
Exhibit 263: SWOT
Exhibit 264: Lupin Ltd. - Overview
Exhibit 265: Lupin Ltd. - Business segments
Exhibit 266: Lupin Ltd. - Key news
Exhibit 267: Lupin Ltd. - Key offerings
Exhibit 268: Lupin Ltd. - Segment focus
Exhibit 269: SWOT
Exhibit 270: Navinta LLC - Overview
Exhibit 271: Navinta LLC - Product / Service
Exhibit 272: Navinta LLC - Key offerings
Exhibit 273: SWOT
Exhibit 274: Nestle SA - Overview
Exhibit 275: Nestle SA - Business segments
Exhibit 276: Nestle SA - Key news
Exhibit 277: Nestle SA - Key offerings
Exhibit 278: Nestle SA - Segment focus
Exhibit 279: SWOT
Exhibit 280: Reckitt Benckiser Group Plc - Overview
Exhibit 281: Reckitt Benckiser Group Plc - Business segments
Exhibit 282: Reckitt Benckiser Group Plc - Key offerings
Exhibit 283: Reckitt Benckiser Group Plc - Segment focus
Exhibit 284: SWOT
Exhibit 285: Recordati S.p.A - Overview
Exhibit 286: Recordati S.p.A - Business segments
Exhibit 287: Recordati S.p.A - Key offerings
Exhibit 288: Recordati S.p.A - Segment focus
Exhibit 289: SWOT
Exhibit 290: Sigmapharm Laboratories LLC - Overview
Exhibit 291: Sigmapharm Laboratories LLC - Product / Service
Exhibit 292: Sigmapharm Laboratories LLC - Key offerings
Exhibit 293: SWOT
Exhibit 294: Swedish Orphan Biovitrum AB - Overview
Exhibit 295: Swedish Orphan Biovitrum AB - Product / Service
Exhibit 296: Swedish Orphan Biovitrum AB - Key offerings
Exhibit 297: SWOT
Exhibit 298: Teva Pharmaceutical Ltd. - Overview
Exhibit 299: Teva Pharmaceutical Ltd. - Business segments
Exhibit 300: Teva Pharmaceutical Ltd. - Key news
Exhibit 301: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 302: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 303: SWOT
Exhibit 304: Inclusions checklist
Exhibit 305: Exclusions checklist
Exhibit 306: Currency conversion rates for US$
Exhibit 307: Research methodology
Exhibit 308: Information sources
Exhibit 309: Data validation
Exhibit 310: Validation techniques employed for market sizing
Exhibit 311: Data synthesis
Exhibit 312: 360 degree market analysis
Exhibit 313: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibit 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 7: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ thousand)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ thousand)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Urea Cycle Disorder Treatment Market 2020 - 2024 ($ thousand)
Exhibit 26: Historic Market Size - Therapy Segment 2020 - 2024 ($ thousand)
Exhibit 27: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ thousand)
Exhibit 28: Historic Market Size - End-user Segment 2020 - 2024 ($ thousand)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ thousand)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Therapy - Market share 2025-2030 (%)
Exhibit 39: Data Table on Therapy - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Therapy
Exhibit 41: Data Table on Comparison by Therapy
Exhibit 42: Chart on Glycerol phenylbutyrate - Market size and forecast 2025-2030 ($ thousand)
Exhibit 43: Data Table on Glycerol phenylbutyrate - Market size and forecast 2025-2030 ($ thousand)
Exhibit 44: Chart on Glycerol phenylbutyrate - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Glycerol phenylbutyrate - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Sodium phenylbutyrate - Market size and forecast 2025-2030 ($ thousand)
Exhibit 47: Data Table on Sodium phenylbutyrate - Market size and forecast 2025-2030 ($ thousand)
Exhibit 48: Chart on Sodium phenylbutyrate - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Sodium phenylbutyrate - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Amino acid supplements - Market size and forecast 2025-2030 ($ thousand)
Exhibit 51: Data Table on Amino acid supplements - Market size and forecast 2025-2030 ($ thousand)
Exhibit 52: Chart on Amino acid supplements - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Amino acid supplements - Year-over-year growth 2025-2030 (%)
Exhibit 54: Chart on Sodium benzoate - Market size and forecast 2025-2030 ($ thousand)
Exhibit 55: Data Table on Sodium benzoate - Market size and forecast 2025-2030 ($ thousand)
Exhibit 56: Chart on Sodium benzoate - Year-over-year growth 2025-2030 (%)
Exhibit 57: Data Table on Sodium benzoate - Year-over-year growth 2025-2030 (%)
Exhibit 58: Chart on Others - Market size and forecast 2025-2030 ($ thousand)
Exhibit 59: Data Table on Others - Market size and forecast 2025-2030 ($ thousand)
Exhibit 60: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 61: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 62: Market opportunity by Therapy ($ thousand)
Exhibit 63: Data Table on Market opportunity by Therapy ($ thousand)
Exhibit 64: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 65: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 66: Chart on Comparison by Route of Administration
Exhibit 67: Data Table on Comparison by Route of Administration
Exhibit 68: Chart on Oral - Market size and forecast 2025-2030 ($ thousand)
Exhibit 69: Data Table on Oral - Market size and forecast 2025-2030 ($ thousand)
Exhibit 70: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 72: Chart on Injectables - Market size and forecast 2025-2030 ($ thousand)
Exhibit 73: Data Table on Injectables - Market size and forecast 2025-2030 ($ thousand)
Exhibit 74: Chart on Injectables - Year-over-year growth 2025-2030 (%)
Exhibit 75: Data Table on Injectables - Year-over-year growth 2025-2030 (%)
Exhibit 76: Market opportunity by Route of Administration ($ thousand)
Exhibit 77: Data Table on Market opportunity by Route of Administration ($ thousand)
Exhibit 78: Chart on End-user - Market share 2025-2030 (%)
Exhibit 79: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 80: Chart on Comparison by End-user
Exhibit 81: Data Table on Comparison by End-user
Exhibit 82: Chart on Hospitals - Market size and forecast 2025-2030 ($ thousand)
Exhibit 83: Data Table on Hospitals - Market size and forecast 2025-2030 ($ thousand)
Exhibit 84: Chart on Hospitals - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Hospitals - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Specialized clinics - Market size and forecast 2025-2030 ($ thousand)
Exhibit 87: Data Table on Specialized clinics - Market size and forecast 2025-2030 ($ thousand)
Exhibit 88: Chart on Specialized clinics - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Specialized clinics - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Home care settings - Market size and forecast 2025-2030 ($ thousand)
Exhibit 91: Data Table on Home care settings - Market size and forecast 2025-2030 ($ thousand)
Exhibit 92: Chart on Home care settings - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Home care settings - Year-over-year growth 2025-2030 (%)
Exhibit 94: Chart on Research institutions - Market size and forecast 2025-2030 ($ thousand)
Exhibit 95: Data Table on Research institutions - Market size and forecast 2025-2030 ($ thousand)
Exhibit 96: Chart on Research institutions - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Research institutions - Year-over-year growth 2025-2030 (%)
Exhibit 98: Market opportunity by End-user ($ thousand)
Exhibit 99: Data Table on Market opportunity by End-user ($ thousand)
Exhibit 100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 101: Chart on Market share by geography 2025-2030 (%)
Exhibit 102: Data Table on Market share by geography 2025-2030 (%)
Exhibit 103: Chart on Geographic comparison
Exhibit 104: Data Table on Geographic comparison
Exhibit 105: Chart on North America - Market size and forecast 2025-2030 ($ thousand)
Exhibit 106: Data Table on North America - Market size and forecast 2025-2030 ($ thousand)
Exhibit 107: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 108: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 109: Chart on Regional Comparison - North America
Exhibit 110: Data Table on Regional Comparison - North America
Exhibit 111: Chart on US - Market size and forecast 2025-2030 ($ thousand)
Exhibit 112: Data Table on US - Market size and forecast 2025-2030 ($ thousand)
Exhibit 113: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Canada - Market size and forecast 2025-2030 ($ thousand)
Exhibit 116: Data Table on Canada - Market size and forecast 2025-2030 ($ thousand)
Exhibit 117: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Mexico - Market size and forecast 2025-2030 ($ thousand)
Exhibit 120: Data Table on Mexico - Market size and forecast 2025-2030 ($ thousand)
Exhibit 121: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Europe - Market size and forecast 2025-2030 ($ thousand)
Exhibit 124: Data Table on Europe - Market size and forecast 2025-2030 ($ thousand)
Exhibit 125: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Regional Comparison - Europe
Exhibit 128: Data Table on Regional Comparison - Europe
Exhibit 129: Chart on Germany - Market size and forecast 2025-2030 ($ thousand)
Exhibit 130: Data Table on Germany - Market size and forecast 2025-2030 ($ thousand)
Exhibit 131: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on UK - Market size and forecast 2025-2030 ($ thousand)
Exhibit 134: Data Table on UK - Market size and forecast 2025-2030 ($ thousand)
Exhibit 135: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on France - Market size and forecast 2025-2030 ($ thousand)
Exhibit 138: Data Table on France - Market size and forecast 2025-2030 ($ thousand)
Exhibit 139: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Italy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 142: Data Table on Italy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 143: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Spain - Market size and forecast 2025-2030 ($ thousand)
Exhibit 146: Data Table on Spain - Market size and forecast 2025-2030 ($ thousand)
Exhibit 147: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
Exhibit 150: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
Exhibit 151: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Asia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 154: Data Table on Asia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 155: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on Regional Comparison - Asia
Exhibit 158: Data Table on Regional Comparison - Asia
Exhibit 159: Chart on China - Market size and forecast 2025-2030 ($ thousand)
Exhibit 160: Data Table on China - Market size and forecast 2025-2030 ($ thousand)
Exhibit 161: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Japan - Market size and forecast 2025-2030 ($ thousand)
Exhibit 164: Data Table on Japan - Market size and forecast 2025-2030 ($ thousand)
Exhibit 165: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on India - Market size and forecast 2025-2030 ($ thousand)
Exhibit 168: Data Table on India - Market size and forecast 2025-2030 ($ thousand)
Exhibit 169: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on South Korea - Market size and forecast 2025-2030 ($ thousand)
Exhibit 172: Data Table on South Korea - Market size and forecast 2025-2030 ($ thousand)
Exhibit 173: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Indonesia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 176: Data Table on Indonesia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 177: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Thailand - Market size and forecast 2025-2030 ($ thousand)
Exhibit 180: Data Table on Thailand - Market size and forecast 2025-2030 ($ thousand)
Exhibit 181: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 184: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 185: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 188: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 189: Chart on Brazil - Market size and forecast 2025-2030 ($ thousand)
Exhibit 190: Data Table on Brazil - Market size and forecast 2025-2030 ($ thousand)
Exhibit 191: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 194: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 195: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on UAE - Market size and forecast 2025-2030 ($ thousand)
Exhibit 198: Data Table on UAE - Market size and forecast 2025-2030 ($ thousand)
Exhibit 199: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Turkey - Market size and forecast 2025-2030 ($ thousand)
Exhibit 202: Data Table on Turkey - Market size and forecast 2025-2030 ($ thousand)
Exhibit 203: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Argentina - Market size and forecast 2025-2030 ($ thousand)
Exhibit 206: Data Table on Argentina - Market size and forecast 2025-2030 ($ thousand)
Exhibit 207: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Colombia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 210: Data Table on Colombia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 211: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on South Africa - Market size and forecast 2025-2030 ($ thousand)
Exhibit 214: Data Table on South Africa - Market size and forecast 2025-2030 ($ thousand)
Exhibit 215: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Israel - Market size and forecast 2025-2030 ($ thousand)
Exhibit 218: Data Table on Israel - Market size and forecast 2025-2030 ($ thousand)
Exhibit 219: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 221: Market opportunity by geography ($ thousand)
Exhibit 222: Data Tables on Market opportunity by geography ($ thousand)
Exhibit 223: Impact of drivers and challenges in 2025 and 2030
Exhibit 224: Overview on criticality of inputs and factors of differentiation
Exhibit 225: Overview on factors of disruption
Exhibit 226: Impact of key risks on business
Exhibit 227: Companies covered
Exhibit 228: Company ranking index
Exhibit 229: Matrix on companies position and classification
Exhibit 230: Abbott Laboratories - Overview
Exhibit 231: Abbott Laboratories - Business segments
Exhibit 232: Abbott Laboratories - Key news
Exhibit 233: Abbott Laboratories - Key offerings
Exhibit 234: Abbott Laboratories - Segment focus
Exhibit 235: SWOT
Exhibit 236: Amgen Inc. - Overview
Exhibit 237: Amgen Inc. - Product / Service
Exhibit 238: Amgen Inc. - Key offerings
Exhibit 239: SWOT
Exhibit 240: ANI Pharmaceuticals Inc. - Overview
Exhibit 241: ANI Pharmaceuticals Inc. - Product / Service
Exhibit 242: ANI Pharmaceuticals Inc. - Key offerings
Exhibit 243: SWOT
Exhibit 244: Bausch Health Companies Inc. - Overview
Exhibit 245: Bausch Health Companies Inc. - Business segments
Exhibit 246: Bausch Health Companies Inc. - Key offerings
Exhibit 247: Bausch Health Companies Inc. - Segment focus
Exhibit 248: SWOT
Exhibit 249: Danone SA - Overview
Exhibit 250: Danone SA - Business segments
Exhibit 251: Danone SA - Key offerings
Exhibit 252: Danone SA - Segment focus
Exhibit 253: SWOT
Exhibit 254: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 255: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 256: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 257: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 258: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 259: SWOT
Exhibit 260: Lucane Pharma SA - Overview
Exhibit 261: Lucane Pharma SA - Product / Service
Exhibit 262: Lucane Pharma SA - Key offerings
Exhibit 263: SWOT
Exhibit 264: Lupin Ltd. - Overview
Exhibit 265: Lupin Ltd. - Business segments
Exhibit 266: Lupin Ltd. - Key news
Exhibit 267: Lupin Ltd. - Key offerings
Exhibit 268: Lupin Ltd. - Segment focus
Exhibit 269: SWOT
Exhibit 270: Navinta LLC - Overview
Exhibit 271: Navinta LLC - Product / Service
Exhibit 272: Navinta LLC - Key offerings
Exhibit 273: SWOT
Exhibit 274: Nestle SA - Overview
Exhibit 275: Nestle SA - Business segments
Exhibit 276: Nestle SA - Key news
Exhibit 277: Nestle SA - Key offerings
Exhibit 278: Nestle SA - Segment focus
Exhibit 279: SWOT
Exhibit 280: Reckitt Benckiser Group Plc - Overview
Exhibit 281: Reckitt Benckiser Group Plc - Business segments
Exhibit 282: Reckitt Benckiser Group Plc - Key offerings
Exhibit 283: Reckitt Benckiser Group Plc - Segment focus
Exhibit 284: SWOT
Exhibit 285: Recordati S.p.A - Overview
Exhibit 286: Recordati S.p.A - Business segments
Exhibit 287: Recordati S.p.A - Key offerings
Exhibit 288: Recordati S.p.A - Segment focus
Exhibit 289: SWOT
Exhibit 290: Sigmapharm Laboratories LLC - Overview
Exhibit 291: Sigmapharm Laboratories LLC - Product / Service
Exhibit 292: Sigmapharm Laboratories LLC - Key offerings
Exhibit 293: SWOT
Exhibit 294: Swedish Orphan Biovitrum AB - Overview
Exhibit 295: Swedish Orphan Biovitrum AB - Product / Service
Exhibit 296: Swedish Orphan Biovitrum AB - Key offerings
Exhibit 297: SWOT
Exhibit 298: Teva Pharmaceutical Ltd. - Overview
Exhibit 299: Teva Pharmaceutical Ltd. - Business segments
Exhibit 300: Teva Pharmaceutical Ltd. - Key news
Exhibit 301: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 302: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 303: SWOT
Exhibit 304: Inclusions checklist
Exhibit 305: Exclusions checklist
Exhibit 306: Currency conversion rates for US$
Exhibit 307: Research methodology
Exhibit 308: Information sources
Exhibit 309: Data validation
Exhibit 310: Validation techniques employed for market sizing
Exhibit 311: Data synthesis
Exhibit 312: 360 degree market analysis
Exhibit 313: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global urea cycle disorder treatment market: Abbott Laboratories, Amgen Inc., ANI Pharmaceuticals Inc., Bausch Health Companies Inc., Danone SA, Dr. Reddys Laboratories Ltd., Immedica Pharma AB, Lucane Pharma SA, Lupin Ltd., Medunik Canada, Navinta LLC, Nestle SA, Orpharma Pty Ltd., Reckitt Benckiser Group Plc, Recordati S.p.A, Sigmapharm Laboratories LLC, Swedish Orphan Biovitrum AB, Teva Pharmaceutical Ltd., Zebra Technologies Corp.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is institutionalization of mrna-based therapeutic interventions and enzyme replacement advancements."
According to the report, one of the major drivers for this market is the mainstreaming of curative gene therapies and industrialization of aav delivery vectors.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Amgen Inc.
- ANI Pharmaceuticals Inc.
- Bausch Health Companies Inc.
- Danone SA
- Dr. Reddys Laboratories Ltd.
- Immedica Pharma AB
- Lucane Pharma SA
- Lupin Ltd.
- Medunik Canada
- Navinta LLC
- Nestle SA
- Orpharma Pty Ltd.
- Reckitt Benckiser Group Plc
- Recordati S.p.A
- Sigmapharm Laboratories LLC
- Swedish Orphan Biovitrum AB
- Teva Pharmaceutical Ltd.
- Zebra Technologies Corp
